All
CURE Media Group Partners with the Lung Cancer Foundation of America
December 28th 2017CURE Media Group, the nation’s leading digital and print media enterprise dedicated to patients and survivors of cancer, has expanded its Strategic Alliance Partnership (SAP) Program by uniting with the Lung Cancer Foundation of America (LCFA).
Foundation Aims For Virtual Trial Registry to Help Patients With Brain Cancer Get Drugs Sooner
December 28th 2017Musella’s plan for the Brain Tumor Virtual Trial Registry is to get patients access to more drugs at a faster pace, while collecting treatment and efficacy information that can later be used by oncologists across the country to treat others.
As Targeted Treatments Multiply, it's Crucial to Identify the Mutations Driving Lung Cancers
December 27th 2017There are a host of treatments available for non-small cell lung cancer (NSCLC) these days, and for patients, perhaps the most crucial step in choosing one is to make sure a pathologist genetically sequences the tumor, so that doctors will know which mutations are driving the cancer.
Will Immunotherapy and Radiation Be Combined in Lung Cancer Treatment?
December 27th 2017Checkpoint inhibitors continue to show promise in the treatment of patients with non-small cell lung cancer (NSCLC), but researchers are now exploring the efficacy of these agents when combined with radiation therapy (RT).
CLL Survivors Worried About Life Expectancy, Quality of Life
December 25th 2017While patients with chronic lymphocytic leukemia (CLL) tend to have long life expectancies, with many prescribed to a “watch-and-wait” approach, a recent study by the Cancer Support Community (CSC) found that more than half of patients living with the disease reported that having CLL affects their viewpoints regarding their life expectancy.
Four-Drug Combination Improves NSCLC Outcomes
December 24th 2017A four-drug combination, including Tecentriq (atezolizumab), Avastin (bevacizumab), carboplatin and paclitaxel, delayed progression or death by 38 percent in patients with advanced non-squamous non–small cell lung cancer (NSCLC), compared to those who were treated with Avastin alone.
Childhood Cancer Survivors at Increased Risk for High Blood Pressure
December 23rd 2017Approximately 420,000 Americans are adult survivors of childhood cancer, and these individuals may be twice as likely to have high blood pressure, also known as hypertension, according to researchers at St. Jude Children’s Research Hospital.